UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches

Molecular psychiatry, 2019-04, Vol.24 (4), p.576-587

2019

Volltextzugriff (PDF)

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia

The American journal of psychiatry, 2019-06, Vol.176 (6), p.457-467

2019

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

The journal of clinical psychiatry, 2015-08, Vol.76 (8), p.1085

2015

Volltextzugriff (PDF)

Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia

The journal of clinical psychiatry, 2016-11, Vol.77 (11), p.1519

2016

Volltextzugriff (PDF)

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2005-04, Vol.293 (13), p.1617

2005

Volltextzugriff (PDF)

Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia

International clinical psychopharmacology, 2016-03, Vol.31 (2), p.69

2016

Volltextzugriff (PDF)

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder

The International journal of eating disorders, 2013-04, Vol.46 (3), p.239-245

2013

Volltextzugriff (PDF)

Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone

Alcoholism, clinical and experimental research, 2006-03, Vol.30 (3), p.480-490

2006

Volltextzugriff (PDF)

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis

Clinical therapeutics, 1999-10, Vol.21 (10), p.1688-1702

1999

Volltextzugriff (PDF)

Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment

Journal of clinical pharmacology, 2005-11, Vol.45 (11), p.1259-1267

2005

Volltextzugriff (PDF)

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review

Clinical therapeutics, 2002-08, Vol.24 (8), p.1225-1291

2002

Volltextzugriff (PDF)

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis

Journal of rheumatology, 2000-11, Vol.27 (11), p.2635

2000

Volltextzugriff (PDF)

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Clinical pharmacology and therapeutics, 1999-03, Vol.65 (3), p.336-347

1999

Volltextzugriff (PDF)

The nature of major histocompatibility complex recognition by γδ T cells

Cell, 1994, Vol.76 (1), p.29-37

1994

Volltextzugriff (PDF)

Molecular Components of T-Cell Recognition

Annual review of immunology, 1992, Vol.10 (1), p.835-873

1992

Volltextzugriff (PDF)

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

Journal of rheumatology, 2001-11, Vol.28 (11), p.2494

2001

Volltextzugriff (PDF)

Naltrexone treatment for alcohol dependency

JAMA : the journal of the American Medical Association, 2005-08, Vol.294 (8), p.899

Ameisen, Olivier

2005

Volltextzugriff (PDF)

Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints

Journal of rheumatology, 2001-12, Vol.28 (12), p.2700

2001

Volltextzugriff (PDF)

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen

The Journal of experimental medicine, 1993-08, Vol.178 (2), p.713-722

1993

Volltextzugriff (PDF)

Association of granuloma annulare with sarcoidosis

Archives of dermatology (1960), 1992-06, Vol.128 (6), p.855

1992

Volltextzugriff (PDF)

A late relapse of Wegener granulomatosis

Annals of internal medicine, 1990-06, Vol.112 (12), p.965

1990

Volltextzugriff (PDF)

A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long-Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence

Alcoholism, clinical and experimental research, 2004-09, Vol.28 (9), p.1356-1361

2004

Volltextzugriff (PDF)

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one‐year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

Arthritis and rheumatism, 2000-05, Vol.43 (5), p.978-987

2000

Volltextzugriff (PDF)

Familial achalasia associated with adrenocortical insufficiency, alacrima, and neurological abnormalities

American journal of medical genetics, 1987-03, Vol.26 (3), p.637-644

1987

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(19)
Male
(14)
Adult
(13)
Female
(13)
Biological And Medical Sciences
(12)
Middle Aged
(11)
Double-Blind Method
(10)
Medical Sciences
(9)
Dose-Response Relationship, Drug
(6)
Psychiatry
(6)
Aged
(5)
Pharmacology & Pharmacy
(5)
Treatment Outcome
(5)
Animals
(4)
Delayed-Action Preparations
(4)
Injections, Intramuscular
(4)
Naltrexone - Administration & Dosage
(4)
Narcotic Antagonists - Administration & Dosage
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder

Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis

Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

The nature of major histocompatibility complex recognition by γδ T cells

Molecular Components of T-Cell Recognition

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

Naltrexone treatment for alcohol dependency

Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen

Association of granuloma annulare with sarcoidosis

A late relapse of Wegener granulomatosis

A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long-Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one‐year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

Familial achalasia associated with adrenocortical insufficiency, alacrima, and neurological abnormalities

Suchergebnisse filtern